Dose Comparison (1 mL versus 2 mL) of Superparamagnetic Tracer for Sentinel Node Biopsy in Early Breast Cancer: Real-World Analysis from 456 Patients
In this large real-world analysis, 1 mL and 2 mL were similar in the clinical performance of SNB in eBC. High detection efficacy was found regardless of tracer timing and BMI. This real-world analysis reinforces SPIO's role as an effective and adaptable alternative to conventional tracers in SNB for eBC.
Authors
- Anne-Sophie Heimes (ORCID: https://orcid.org/0000-0001-5472-5224)
- Kathrin Stewen
- Ina Shehaj (ORCID: https://orcid.org/0009-0001-3304-5040)
- Amelie Löwe
- S. Krajnak
- Antje Lebrecht
- Annette Hasenburg
- Paul Löwe
Institutions
- Goethe University Frankfurt (DE)
- Johannes Gutenberg University Mainz (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- St. Marien Hospital (DE)
- Agaplesion Markus Hospital (DE)
Publication Details
- Journal
- Breast Care
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1159/000550609
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00